Additionally, the combination of the adiponectin and interleukin-1 receptor antagonist (IL-1Ra), which was elevated in PC patients with DM compared to those with T2DM and the healthy controls showed strong diagnostic potential for the distinction of PCRD from T2DM [60]. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.